Beth T Harrison

6PUBLICATIONS
37CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 16, 2025
Clinicogenomic Characterization of Inflammatory Breast Cancer.

Nolan Priedigkeit, Beth Harrison, Robert Shue

|Jun 02, 2023
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.

Ana C Garrido-Castro, Meredith M Regan, Samuel M Niman

|Apr 28, 2022
Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity.

T Rinda Soong, Deborah A Dillon, Travis L Rice-Stitt

|Oct 20, 2020
Detection of ERBB2 amplification in uterine serous carcinoma by next-generation sequencing: an approach highly concordant with standard assays.

Carrie L Robinson, Beth T Harrison, Azra H Ligon

|Apr 18, 2020
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer.

Emily S Reisenbichler, Gang Han, Andrew Bellizzi

|Jan 15, 2020
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.

Beth T Harrison, Faina Nakhlis, Deborah A Dillon

Pageof 1